focus -WSS

focus

author：entertainment 2025-10-03 00:08:18 - browse：2839

Stock exchange — Drew Angerer/Getty Images

Viking Therapeutics said Tuesday that its closely watched oral obesity drug had succeeded in an early-stage trial and that it planned to advance the medicine into the next phase of development.

The top-line results released Tuesday were only from a Phase 1 study, which primarily focuses on a drug’s safety. But Viking said that in the study, its medicine led to a roughly 3.3% placebo-adjusted average weight loss after four weeks and that it showed no safety issues.

In preview notes, analysts had said that investors would want to see between 3% and 4% placebo-adjusted weight loss. Shares of San Diego-based Viking were up more than 20% in pre-market trading Tuesday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： PhRMA lawsuit over Medicare drug price negotiation tossed

WSS

Hundreds of thousands march in Israel. Former security chiefs beg Netanyahu to halt legal overhaul

The response to Covid

Thousands protest mob assault of women who were paraded naked in remote Indian border state

Burning questions about Delta and the next phase of the Covid pandemic

What should King Charles tell the public about his cancer?

Private equity deals in Medicare Advantage declines

focus

focus

entertainment

Sports medicine is finally prioritizing gender equality

A disappointing year of Humira biosimilars

Walensky prepares to leave CDC — and Congress — behind

Woman found dead after suspected bear encounter near Yellowstone, wildlife officials say

The high cost of giving birth even with insurance

'The Earth is screaming at us': Gov. Inslee calls for climate action amid record heat

Wildfire smoke exposes gaps in outdoor worker protections

Medicare Advantage proposed rates disappoint insurers

Psychedelics group wrestles with new pharma identity

Malaysia cuts short music fest after British band slams anti

hotspot

Biden report: The neurospychology of memory and aging

How digital tools helped lower hypertension in marginalized patients

Weekend shootings leave at least 6 dead, 20 others wounded in Chicago

The response to Covid

KalVista pill reduced swelling 'attacks' caused by genetic disease

What we’ve learned from the Aduhelm mess

leisure time

hotspot

leisure time

hotspot